Home | Publications | Research (R&D) | Pipeline place holder
place holder place holder

Pipeline

Hologic, Inc. Product Pipeline Analysis


Publication Date   August 2008
Publisher   Global Markets Direct
Product Type   Report
Pages   63
ISBN Number   not applicable
Product Code   GMD658
Ask a question about this product?

Price £505.00

approximately: $753 | €602

Summary


This report is an insightful source for data, analysis and strategic insights into a Hologic, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content


  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Diagnostic Imaging
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Mammography/Breast Care
      • 3.2.1 Overview
      • 3.2.2 Financials
      • 3.2.3 Capital Expenditure
      • 3.2.4 Market View
    • 3.3 Osteoporosis Assessment
      • 3.3.1 Overview
      • 3.3.2 Financials
      • 3.3.3 Capital Expenditure
    • 3.4 Other
      • 3.4.1 Overview
      • 3.4.2 Financials
      • 3.4.3 Capital Expenditure
    • 3.5 Major Products and Services
      • 3.5.1 Overview
  • 4 History
  • 5 Business Strategy
    • 5.1 Mission Statement
    • 5.2 Strategy
  • 6 Value Chain Analysis
    • 6.1 Manufacturing
      • 6.1.1 In House Manufacturing
      • 6.1.2 Outsourcing
    • 6.2 Product Development
      • 6.2.1 Regulatory Approvals
      • 6.2.2 Clinical Trials
      • 6.2.3 Research and Development
    • 6.3 Sales and Marketing
      • 6.3.1 Partnerships and Alliances
  • 7 Competitors
  • 8 Share Holding Structure
  • 9 Key Employees
  • 10 Key Employee Biographies
  • 11 Company Statement
  • 12 Locations And Subsidiaries
    • 12.1 Head Office
    • 12.2 Other Locations & Subsidiaries
  • 13 Recent Developments
    • 13.1 Financial Announcements
      • 13.1.1 Jul 30, 2008: Hologic Reports 3Q Fiscal 2008 Results
      • 13.1.2 May 01, 2008: Hologic Reports Q2 Fiscal 2008 Results
      • 13.1.3 Apr 24, 2008: Hologic To Release Q2 Fiscal 2008 Results
      • 13.1.4 Jan 30, 2008: Hologic Approves Two-For-One Stock Split
      • 13.1.5 Nov 06, 2007: Hologic Reports Q4 Fiscal 2007 Results
      • 13.1.6 Jul 31, 2007: Hologic Reports Q3 Fiscal 2007 Results
      • 13.1.7 May 01, 2007: Hologic Reports Q2 Fiscal 2007 Results
      • 13.1.8 Jan 31, 2007: Hologic Reports Q1 Fiscal 2007 Results
      • 13.1.9 Nov 08, 2006: Hologic Reports Q4 Fiscal 2006 Results
      • 13.1.10 Jul 25, 2006: Hologic Reports Q3 Fiscal 2006 Results
    • 13.2 Corporate Communications
      • 13.2.1 May 20, 2008: Hologic Announces Organizational Change
      • 13.2.2 Dec 19, 2007: Hologic To Join NASDAQ-100 Index
      • 13.2.3 Oct 22, 2007: Hologic Appoints Chairman
    • 13.3 Legal and Regulatory
      • 13.3.1 Feb 14, 2008: Tissue Extraction Devices Files Lawsuit Against Hologic And Its Subsidiary
    • 13.4 Product News
      • 13.4.1 Jun 02, 2008: New Dimension In Detection
      • 13.4.2 Feb 25, 2008: Three Year Analysis Of Treatment Efficacy, Cosmesis, and Toxicity Support Use Of The Hologic MammoSite Radiation Therapy System
      • 13.4.3 Dec 14, 2007: FDA Advisory Panel Finds Hologic, Inc. Adiana(R) Permanent Contraception Approvable
      • 13.4.4 Oct 11, 2007: Defining The Standard Of Care In Women''s Health
      • 13.4.5 Dec 02, 2003: Hologic Unveils Revolutionary New Technology At RSNA 2003
    • 13.5 Clinical Trials
      • 13.5.1 Feb 25, 2008: Three Year Analysis Of Treatment Efficacy, Cosmesis, and Toxicity Support Use Of The Hologic MammoSite Radiation Therapy System
    • 13.6 Other Significant Developments
      • 13.6.1 Sep 22, 2005: Hologic Obtains US Distribution Rights For Esaote Line Of Extremity MRI Imaging Systems
  • 14 Hologic, Inc. Pipeline Products
    • 14.1 Hologic, Inc. Product Pipeline Analysis
      • 14.1.1 Hologic, Inc. Pipeline Products By Equipment Type
      • 14.1.2 Hologic, Inc. Pipeline Products By Development Stage
      • 14.1.3 Hologic, Inc. Pipeline Products By Therapy Area
      • 14.1.4 Hologic, Inc. Pipeline Products By Clinical Trials
      • 14.1.5 Hologic, Inc. Pipeline Products By News Summary
    • 14.2 Breast tomosynthesis system
      • 14.2.1 Product Description
      • 14.2.2 Product Status
      • 14.2.3 Clinical Trials
      • 14.2.4 Product Milestone
    • 14.3 Discovery Bone Densitometers
      • 14.3.1 Product Description
      • 14.3.2 Product Status
      • 14.3.3 Product Milestone
    • 14.4 Opera E-MRI
      • 14.4.1 Product Description
      • 14.4.2 Product Status
    • 14.5 Quantra
      • 14.5.1 Product Description
      • 14.5.2 Product Status
    • 14.6 GliaSite RTS
      • 14.6.1 Product Description
      • 14.6.2 Product Status
      • 14.6.3 Clinical Trials
    • 14.7 MammoSite Radiation Therapy System
      • 14.7.1 Product Description
      • 14.7.2 Product Status
      • 14.7.3 Clinical Trials
      • 14.7.4 Product Milestone
  • 15 Appendix
    • 15.1 Methodology
      • 15.1.1 Coverage
      • 15.1.2 Secondary Research
      • 15.1.3 Primary Research
      • 15.1.4 Expert Panel Validation
    • 15.2 Contact Us
    • 15.3 About Global Markets Direct
    • 15.4 Disclaimer
  • 1 List of Tables
    • Table 1: Hologic, Inc.,Key Facts, 2007
    • Table 2: Hologic, Inc., Share Holding Structure
    • Table 3: Hologic, Inc., Key Employees, 2007
    • Table 4: Hologic, Inc., Other Locations
    • Table 5: Hologic, Inc. Pipeline Products by Equipment Type
    • Table 6: Hologic, Inc. Pipeline Products By Development Stage
    • Table 7: Hologic, Inc. Pipeline Products By Therapy Area
    • Table 8: Hologic, Inc. Pipeline Products By Clinical Trials
    • Table 9: Hologic, Inc. Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Hologic, Inc., Value Chain Analysis
    • Figure 2: Hologic, Inc. Pipeline Products By Equipment Type
    • Figure 3: Hologic, Inc. Pipeline Products By Equipment Type
    • Figure 4: Hologic, Inc. Pipeline Products By Development Stage
    • Figure 5: Hologic, Inc. Pipeline Products By News Summary
    • Figure 6: Global Markets Direct Methodology